Raul Bortolin, Phd
AeroLeads people directory · profile

Raul Bortolin, Phd Email & Phone Number

Scientist | Expert in Stem Cell & Gene Therapy, Pharmacology & Toxicology | Novel Target Discovery Specialist | Strategic & Creative Problem Solver | Cooking Enthusiast at Yoh, A Day & Zimmermann Company
Location: Boston, Massachusetts, United States 8 work roles 3 schools
1 work email found @yahoo.com.br LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 86%

Contact Signals · 1 work email

Work email r****@yahoo.com.br
LinkedIn Profile matched
3 free lookups remaining · No credit card
Role
Scientist | Expert in Stem Cell & Gene Therapy, Pharmacology & Toxicology | Novel Target Discovery Specialist | Strategic & Creative Problem Solver | Cooking Enthusiast
Location
Boston, Massachusetts, United States
Company size

Who is Raul Bortolin, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Raul Bortolin, Phd is listed as Scientist | Expert in Stem Cell & Gene Therapy, Pharmacology & Toxicology | Novel Target Discovery Specialist | Strategic & Creative Problem Solver | Cooking Enthusiast at Yoh, A Day & Zimmermann Company, a with 1352 employees, based in Boston, Massachusetts, United States. AeroLeads shows a work email signal at yahoo.com.br and a matched LinkedIn profile for Raul Bortolin, Phd.

Raul Bortolin, Phd previously worked as Scientist at Yoh, A Day & Zimmermann Company and Instructor at Harvard Medical School. Raul Bortolin, Phd holds Phd, Pharmacology from Universidade Federal Do Rio Grande Do Norte.

Company email context

Email format at Yoh, A Day & Zimmermann Company

This section adds company-level context without repeating Raul Bortolin, Phd's masked contact details.

*@yahoo.com.br
68% confidence

AeroLeads found 1 current-domain work email signal for Raul Bortolin, Phd. Compare company email patterns before reaching out.

Profile bio

About Raul Bortolin, Phd

I am an experienced pharmaceutical researcher with a deep commitment to advancing the field of pharmacology, toxicology, and biomarker discovery. Over the past 9 years, I have been particularly focused on cardiometabolic diseases, exploring gene therapies for cardiac conditions, evaluating drug-induced toxicity, and searching for novel therapeutic and early diagnostic targets, contributing to over 50 peer-reviewed publications and securing a patent in the process.My core expertise lies in the design and implementation of clinical, in vitro, and in vivo studies, all essential for advancing translational medicine and personalized healthcare solutions. I have led multiple projects, effectively translating complex research into viable drug candidates ready for clinical trials, thus accelerating their path to real-world applicationI specialize in iPSC technology, mastering the use of cardiomyocytes, hepatocytes, and skeletal muscle cells across both traditional and advanced 3D cultures. My work in optimizing the process of establishing master cell banks has significantly streamlined the phases of drug development, ensuring efficiency and effectiveness.Throughout my career, I have also focused on mentoring a dynamic team of researchers, fostering their growth, and overseeing the successful completion of numerous projects. My ability to collaborate effectively has allowed me to build and nurture valuable partnerships that enhance our collective research impact, directly benefiting patient care.I am passionate about contributing to an environment that values meticulous research, collaborative spirit, and innovative breakthroughs. I thrive in settings that appreciate proactive leadership and flexibility, and I am dedicated to making meaningful contributions that enhance both scientific understanding and patient outcomes.I am excited about the opportunity to join a team that is equally committed to making significant advances in healthcare. Please feel free to connect with me at rhbortolin@gmail.com to discuss how we can collaborate or how my expertise might align with the strategic goals of your organization.

Current workplace

Raul Bortolin, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

Yoh, A Day & Zimmermann Company
Yoh, A Day & Zimmermann Company
Scientist | Expert in Stem Cell & Gene Therapy, Pharmacology & Toxicology | Novel Target Discovery Specialist | Strategic & Creative Problem Solver | Cooking Enthusiast
philadelphia, pennsylvania, united states
Website
Employees
1352
AeroLeads page
8 roles

Raul Bortolin, Phd work experience

A career timeline built from the work history available for this profile.

Instructor

Boston, Massachusetts, United States

■ Developed novel translational RNA-based gene therapies for genetic cardiac diseases.■ Conducted pharmacodynamics and toxicology assessments in iPSC-derived cardiomyocytes and genome-edited cell lines.■ Led preclinical in vivo characterization in transgenic animal models.

May 2023 - Aug 2024

Research Fellow

Boston, Massachusetts, United States

■ Designed and implemented large-scale SOPs to create iPSC-derived cardiomyocytes 3D/organoids in bioreactors for preclinical studies.■ Established an iPSC master cell bank reprogrammed from 25 patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) for precision medicine studies.■ Mentored 2 research assistants and 2 undergraduate students in stem cell biology

Jan 2022 - May 2023

Senior Scientist

Boston, Massachusetts, United States

Boston Children's Hospital is a teaching hospital affiliated with Harvard Medical School where my postdoctoral research is being developed (BCH/HMS double affiliation).

May 2023 - Aug 2024

Research Fellow

Boston, Massachusetts, United States

Boston Children's Hospital is a teaching hospital affiliated with Harvard Medical School where my postdoctoral research is being developed (BCH/HMS double affiliation).

Jan 2022 - May 2023

Postdoctoral Research Fellow

■ Developed a metabolic modeling platform for in vitro study, drug screening, and biomarker discovery using iPSC-derived hepatocytes and gene-edited HepG2 cell lines. ■ Expert in developing iPSC-derived skeletal muscle platforms to evaluate lipid-lowering-induced myotoxicity.■ Established an iPSC master cell bank reprogrammed from 6 familial hypercholesterolemic patients.■ Analyzed lipidomic, genomics, epigenomics, and pharmacogenomics data for precision medicine.■ Conducted comprehensive dataset analysis to identify, characterize, and validate genomic, biochemical, and pharmacogenomic targets, supporting early diagnosis, drug efficacy evaluation, toxicity assessment, and advancements in precision medicine.■ Mentored 1 undergraduate student in biomarker discovery.

Jun 2018 - Jan 2022

Postdoctoral Research Fellow

■ Performed clinical data analysis for diagnostics and precision medicine in cardiovascular disease and diabetes. ■ Developed in silico and in vitro assays for drug-induced liver toxicity using exosome-derived miRNAs. ■ Developed and patented a herbal-based medicine for type 1 diabetes, demonstrating significant efficacy in animal models. (patent No: BR1020190185104).■ Evaluated herbal compounds with satiogenic properties using a food-induced obesity model in rats, assessing potential treatments for obesity.■ Mentored 2 undergraduate students, 4 professionals, 3 Master and 2 Ph.D. students in molecular biology.

Jan 2015 - Jun 2018
Team & coworkers

Colleagues at Yoh, A Day & Zimmermann Company

Other employees you can reach at yoh.com. View company contacts for 1352 employees →

3 education records

Raul Bortolin, Phd education

Bachelor Of Pharmacy - Bpharm, Pharmacology

Undergraduate Dissertation: Determination of the Anti-Hyperglycemic Effect of Casearia Sylvestris in the Treatment of Diabetes Mellitus.

FAQ

Frequently asked questions about Raul Bortolin, Phd

Quick answers generated from the profile data available on this page.

What company does Raul Bortolin, Phd work for?

Raul Bortolin, Phd works for Yoh, A Day & Zimmermann Company.

What is Raul Bortolin, Phd's role at Yoh, A Day & Zimmermann Company?

Raul Bortolin, Phd is listed as Scientist | Expert in Stem Cell & Gene Therapy, Pharmacology & Toxicology | Novel Target Discovery Specialist | Strategic & Creative Problem Solver | Cooking Enthusiast at Yoh, A Day & Zimmermann Company.

What is Raul Bortolin, Phd's email address?

AeroLeads has found 1 work email signal at @yahoo.com.br for Raul Bortolin, Phd at Yoh, A Day & Zimmermann Company.

Where is Raul Bortolin, Phd based?

Raul Bortolin, Phd is based in Boston, Massachusetts, United States while working with Yoh, A Day & Zimmermann Company.

What companies has Raul Bortolin, Phd worked for?

Raul Bortolin, Phd has worked for Yoh, A Day & Zimmermann Company, Harvard Medical School, Boston Children'S Hospital, Universidade De São Paulo, and Universidade Federal Do Rio Grande Do Norte.

Who are Raul Bortolin, Phd's colleagues at Yoh, A Day & Zimmermann Company?

Raul Bortolin, Phd's colleagues at Yoh, A Day & Zimmermann Company include Kimberly Kallelis, Salam Ningwal, Hmidan, Zaid, Casey Troost, and Elizabeth Mccain.

How can I contact Raul Bortolin, Phd?

You can use AeroLeads to view verified contact signals for Raul Bortolin, Phd at Yoh, A Day & Zimmermann Company, including work email, phone, and LinkedIn data when available.

What schools did Raul Bortolin, Phd attend?

Raul Bortolin, Phd holds Phd, Pharmacology from Universidade Federal Do Rio Grande Do Norte.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.